查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1787231

全球神經栓塞設備市場

Neurovascular Embolization Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 284 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球神經栓塞設備市場規模將達到 15 億美元

全球神經血管栓塞裝置市場規模預計在2024年達到12億美元，預計在2024-2030年的分析期內將以4.6%的複合年成長率成長，到2030年將達到15億美元。栓塞線圈是本報告分析的細分市場之一，預計其複合年成長率為3.6%，到分析期結束時市場規模將達到5.796億美元。血流改道裝置細分市場在分析期間的複合年成長率預計為3.8%。

美國市場規模估計為 3.154 億美元，中國市場預計複合年成長率為 7.1%

美國神經栓塞器材市場規模預計在2024年達到3.154億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到2.94億美元，在分析期間（2024-2030年）的複合年成長率為7.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為2.2%和4.6%。在歐洲，德國的複合年成長率預計為2.9%。

全球神經栓塞設備市場—主要趨勢與促進因素摘要

為什麼神經栓塞裝置對於治療中風和動脈瘤至關重要？

神經血管栓塞裝置已成為顱內動脈瘤、動靜脈畸形 (AVM) 和其他腦血管異常治療的重要組成部分。微創裝置，例如栓塞線圈、液體栓塞劑、血流轉向器和血管栓塞，旨在防止動脈瘤破裂、減少流向異常血管的血流並穩定腦循環。隨著中風和出血性疾病成為全球致殘和死亡的主要原因，神經血管栓塞已成為開顱手術和夾閉術等傳統外科手術介入的有效替代方案。血管內治療的進展顯著改善了患者的預後，縮短了復原時間並減少了治療後併發症。尤其是血流轉向器，已成為治療以前被認為無法手術的複雜寬頸頸部的突破性技術。此外，液體栓塞劑透過精確閉塞血管並降低復發性出血的風險，正在徹底改變 AVM 的治療。隨著全球神經血管疾病負擔的增加，對栓塞裝置的需求也在增加，推動了介入神經放射學治療的進一步技術創新和應用。

哪些挑戰阻礙了神經栓塞裝置的普及？

儘管神經栓塞裝置的療效已得到證實，但仍有幾個挑戰阻礙了其廣泛應用。一個主要問題是血管內栓塞的高成本，限制了其在醫療資源有限地區的普及。此外，栓塞技術複雜，需要訓練有素的介入神經放射學，限制了其在農村地區和醫療體係不已開發地區應用。另一個主要挑戰是手術併發症的風險，包括血管穿孔、缺血和栓塞物質移位，這些併發症可能導致中風和神經病變。此外，患者解剖和血管狀況的多變性需要個別化治療計劃，這需要先進的影像學檢查和廣泛的術前評估。新栓塞技術的監管障礙和漫長的核准週期進一步減緩了市場擴張，並推遲了獲得下一代神經血管治療的機會。此外，患者對微創神經血管介入的認知仍然很低，導致診斷延遲和栓塞治療利用不足。應對這些挑戰需要加強對醫生培訓的投資，提高設備的安全性和準確性，並加強努力使栓塞治療更加普及且價格更實惠。

技術創新如何提高神經栓塞裝置的有效性？

神經血管栓塞領域的技術進步日新月異，提高了手術成功率並擴大了複雜腦血管疾病的治療選擇。其中最重要的創新之一是生物活性栓塞線圈的開發。這些線圈透過促進內皮細胞增生來加速動脈瘤閉塞並促進長期血管癒合。此外，第二代流量轉向器的引入提高了靈活性和流量控制能力，提高了治療大型寬頸部動脈瘤的安全性和有效性。人工智慧驅動的影像和機器人輔助血管內導航的結合實現了精準栓塞，最大限度地降低了併發症的風險，並改善了患者的預後。增強黏度控制的液體栓塞劑也透過提高對目標血管結構的滲透性和黏附性，促進了 AVM 的治療。此外，聯合治療，例如栓塞後進行神經保護藥物干預，進一步最佳化了神經血管治療策略。隨著設備製造商不斷改進栓塞技術，介入神經放射學手術變得更加安全、高效，並且更容易更廣泛的患者接受。

是什麼推動了神經栓塞設備市場的成長？

神經血管栓塞器械市場的成長受到多種因素的推動，包括腦血管疾病盛行率的上升、微創手術的普及以及血管內治療技術的不斷進步。由於人口老化以及高血壓和吸菸等生活方式相關的風險因素，顱內動脈瘤 (AVM) 的發生率不斷上升，對有效的神經血管介入治療的需求也日益旺盛。由於栓塞手術與開放性手術相比，其發生率更低、住院時間更短，因此向微創技術的轉變進一步推動了市場擴張。栓塞材料（包括生物可吸收和滲透性線栓塞劑）的技術進步，正在提高手術的準確性和安全性。此外，3D 旋轉血管造影術和灌注磁振造影 (MRI) 等先進神經影像技術的日益普及，也透過改進診斷和治療計劃，推動了其應用率的提高。報銷政策的擴大以及政府旨在發展中風治療基礎設施的舉措，也在市場成長中發揮關鍵作用。隨著醫療保健提供者和研究機構繼續投資於神經血管創新，神經血管栓塞設備市場預計將大幅擴大，為患有複雜腦血管疾病的患者提供挽救生命的解決方案。

部分

產品類型（栓塞線圈、血流改道裝置、液體栓塞劑、動脈瘤夾）、最終用戶（醫院最終用戶、專科診所最終用戶、其他最終用戶）

受訪公司範例

  • Abbott Laboratories
  • Acandis GmbH
  • ASAHI INTECC CO., LTD.
  • B. Braun Melsungen AG
  • Balt SAS
  • Cerus Endovascular
  • Imperative Care
  • Integer Holdings Corporation
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.（CERENOVUS）
  • Medikit Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • MicroVention, Inc.（Terumo Corporation）
  • Penumbra, Inc.
  • Perflow Medical Ltd.
  • Phenox GmbH
  • Shape Memory Medical
  • Stryker Corporation

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP32332

Global Neurovascular Embolization Devices Market to Reach US$1.5 Billion by 2030

The global market for Neurovascular Embolization Devices estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Embolic Coils, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$579.6 Million by the end of the analysis period. Growth in the Flow Diversion Devices segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$315.4 Million While China is Forecast to Grow at 7.1% CAGR

The Neurovascular Embolization Devices market in the U.S. is estimated at US$315.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$294.0 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Neurovascular Embolization Devices Market - Key Trends & Drivers Summarized

Why Are Neurovascular Embolization Devices Essential in Stroke and Aneurysm Treatment?

Neurovascular embolization devices have become critical in the management of intracranial aneurysms, arteriovenous malformations (AVMs), and other cerebrovascular abnormalities. These minimally invasive devices, including embolic coils, liquid embolic agents, flow diverters, and vascular plugs, are designed to prevent aneurysm rupture, reduce blood flow to abnormal vessels, and stabilize cerebral circulation. With stroke and hemorrhagic conditions being leading causes of disability and mortality worldwide, neurovascular embolization procedures are gaining traction as an effective alternative to traditional surgical interventions such as craniotomy and clipping. The advancement of endovascular techniques has significantly improved patient outcomes, reducing recovery times and post-procedural complications. In particular, flow diverters have emerged as a game-changing technology for treating wide-necked and complex aneurysms that were previously considered inoperable. Additionally, liquid embolic agents are revolutionizing AVM treatment by allowing precise vessel occlusion, reducing the risk of recurrent hemorrhage. As the global burden of neurovascular diseases rises, the demand for embolization devices is increasing, driving further innovation and adoption in neurointerventional procedures.

What Challenges Are Hindering the Adoption of Neurovascular Embolization Devices?

Despite their proven efficacy, several challenges hinder the widespread adoption of neurovascular embolization devices. One of the primary concerns is the high cost of endovascular embolization procedures, making them less accessible in regions with limited healthcare funding. Additionally, the technical complexity of embolization procedures requires highly trained neurointerventionalists, limiting availability in rural and underdeveloped healthcare systems. Another significant challenge is the risk of procedural complications, including vessel perforation, ischemia, and migration of embolic materials, which can lead to stroke or neurological deficits. The variability in patient anatomy and vascular conditions also necessitates personalized treatment planning, requiring advanced imaging and extensive pre-procedural evaluation. Regulatory hurdles and long approval cycles for new embolization technologies further slow down market expansion, delaying access to next-generation neurovascular treatments. Moreover, patient awareness about minimally invasive neurovascular interventions remains low, leading to delayed diagnosis and underutilization of embolization therapies. Addressing these challenges will require greater investment in physician training, improvements in device safety and precision, and increased efforts to make embolization procedures more widely available and affordable.

How Are Innovations Enhancing the Effectiveness of Neurovascular Embolization Devices?

The field of neurovascular embolization is witnessing rapid technological advancements that are improving procedural success rates and expanding treatment options for complex cerebrovascular conditions. One of the most significant innovations is the development of bioactive embolic coils, which promote faster aneurysm occlusion and long-term vessel healing by encouraging endothelial cell growth. Additionally, the introduction of second-generation flow diverters with improved flexibility and flow modulation capabilities is enhancing treatment safety and effectiveness for large and wide-necked aneurysms. The integration of AI-powered imaging and robotic-assisted endovascular navigation is enabling precise embolization procedures, minimizing the risk of complications and improving patient outcomes. Liquid embolic agents with enhanced viscosity control are also advancing AVM treatment by providing better penetration and adhesion to targeted vascular structures. Moreover, the emergence of combination therapies-such as embolization followed by neuroprotective pharmacological interventions-is further optimizing neurovascular treatment strategies. As device manufacturers continue to refine embolization technologies, neurointerventional procedures are becoming safer, more efficient, and accessible to a broader patient population.

What Is Driving the Growth of the Neurovascular Embolization Devices Market?

The growth in the neurovascular embolization devices market is driven by several factors, including the rising prevalence of cerebrovascular diseases, increasing adoption of minimally invasive procedures, and continuous advancements in endovascular technology. The growing incidence of intracranial aneurysms and AVMs, fueled by aging populations and lifestyle-related risk factors such as hypertension and smoking, is creating a strong demand for effective neurovascular interventions. The shift toward minimally invasive techniques is further accelerating market expansion, as embolization procedures offer lower morbidity and shorter hospital stays compared to open surgeries. Technological advancements in embolization materials, including bioresorbable and radiopaque embolic agents, are enhancing procedural precision and safety. Additionally, the increasing availability of advanced neuroimaging techniques, such as 3D rotational angiography and perfusion MRI, is improving diagnosis and treatment planning, driving higher adoption rates. Expanding reimbursement policies and government initiatives aimed at improving stroke care infrastructure are also playing a crucial role in market growth. As healthcare providers and research institutions continue to invest in neurovascular innovation, the neurovascular embolization devices market is poised for substantial expansion, offering life-saving solutions for patients with complex cerebrovascular conditions.

SCOPE OF STUDY:

The report analyzes the Neurovascular Embolization Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents, Aneurysm Clips); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Acandis GmbH
  • ASAHI INTECC CO., LTD.
  • B. Braun Melsungen AG
  • Balt SAS
  • Cerus Endovascular
  • Imperative Care
  • Integer Holdings Corporation
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc. (CERENOVUS)
  • Medikit Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • MicroVention, Inc. (Terumo Corporation)
  • Penumbra, Inc.
  • Perflow Medical Ltd.
  • Phenox GmbH
  • Shape Memory Medical
  • Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Neurovascular Embolization Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Aneurysms and Stroke Cases Throws the Spotlight on Neurovascular Embolization Devices
    • Increasing Geriatric Population Base Globally Spurs Demand for Minimally Invasive Neurovascular Interventions
    • Technological Advancements in Detachable Coils and Liquid Embolic Agents Propel Market Growth
    • Development of Bioresorbable and Next-Generation Embolic Materials Expands Addressable Market Opportunity
    • Integration of AI and Image-Guided Navigation in Neurovascular Procedures Strengthens Business Case for Device Innovation
    • Growing Physician Preference for Endovascular Over Open Neurosurgery Drives Adoption of Embolization Devices
    • Government-Led Stroke Awareness Campaigns Accelerate Demand for Early Diagnosis and Intervention Tools
    • Rising Healthcare Spending in Emerging Markets Unlocks New Revenue Pools for Neurovascular Device Manufacturers
    • Increasing Hospital Investments in Hybrid Operating Rooms Creates Favorable Ecosystem for Advanced Embolization Devices
    • Surge in Interventional Neuroradiology Training Programs Sustains Growth in Skilled Workforce and Procedure Volumes
    • Rapid Shift Towards Outpatient and Ambulatory Neurosurgical Centers Spurs Demand for Compact and Easy-to-Use Devices
    • Ongoing Clinical Trials and Evidence-Based Approvals Strengthen Regulatory Confidence and Propel Commercial Uptake
    • Strategic Collaborations Between Device Companies and Academic Research Institutions Drive Innovation Pipeline
    • Increasing Reimbursement Coverage for Neurovascular Interventions Bolsters Market Accessibility and Uptake
    • Emergence of Flow Diversion Techniques as Adjunct to Embolization Expands Treatment Landscape
    • Rising Demand for Personalized Medicine Approaches Drives Interest in Customized Embolic Therapies
    • Growing Concerns Around Device Safety and Adverse Events Pose Regulatory Challenges and Slow Down Approvals
    • Increasing Use of Big Data and Predictive Analytics in Treatment Planning Enhances Clinical Outcomes and Device Use
    • Expansion of Tele-Neurointervention Capabilities in Remote Areas Propels Demand for Portable Embolization Systems
    • Advancements in 3D Printing of Neurovascular Models Facilitate Physician Training and Drive Confidence in Device Usage
    • Intensifying Competition Among Market Players Drives Pricing Pressures but Also Fuels Innovation in Product Differentiation
    • Regulatory Harmonization Across Key Markets Reduces Time-to-Market and Supports Global Expansion of Embolization Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurovascular Embolization Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurovascular Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Embolic Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Embolic Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Embolic Coils by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Flow Diversion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Flow Diversion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Flow Diversion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Liquid Embolic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Liquid Embolic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Liquid Embolic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Aneurysm Clips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Aneurysm Clips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Aneurysm Clips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Neurovascular Embolization Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Neurovascular Embolization Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Neurovascular Embolization Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Neurovascular Embolization Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION